Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-13-000351
Filing Date
2013-01-31
Accepted
2013-01-31 16:16:03
Documents
2
Period of Report
2013-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K FILING DOCUMENT document.htm 6-K 4525
2 PRESS RELEASE newsrelease.htm EX-99 10283
  Complete submission text file 0001171843-13-000351.txt   15871
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
TEKMIRA PHARMACEUTICALS Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-34949 | Film No.: 13562850
SIC: 2834 Pharmaceutical Preparations